Cargando…
Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996355/ https://www.ncbi.nlm.nih.gov/pubmed/35405739 http://dx.doi.org/10.1182/bloodadvances.2022007172 |
| _version_ | 1784903026860883968 |
|---|---|
| author | Abbas, Hussein A. Sun, Hanxiao Pierce, Sherry Kanagal-Shamanna, Rashmi Li, Ziyi Yilmaz, Musa Borthakur, Gautam DiPippo, Adam J. Jabbour, Elias Konopleva, Marina Short, Nicholas J. DiNardo, Courtney Daver, Naval Ravandi, Farhad Kadia, Tapan M. |
| author_facet | Abbas, Hussein A. Sun, Hanxiao Pierce, Sherry Kanagal-Shamanna, Rashmi Li, Ziyi Yilmaz, Musa Borthakur, Gautam DiPippo, Adam J. Jabbour, Elias Konopleva, Marina Short, Nicholas J. DiNardo, Courtney Daver, Naval Ravandi, Farhad Kadia, Tapan M. |
| author_sort | Abbas, Hussein A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9996355 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99963552023-03-10 Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy Abbas, Hussein A. Sun, Hanxiao Pierce, Sherry Kanagal-Shamanna, Rashmi Li, Ziyi Yilmaz, Musa Borthakur, Gautam DiPippo, Adam J. Jabbour, Elias Konopleva, Marina Short, Nicholas J. DiNardo, Courtney Daver, Naval Ravandi, Farhad Kadia, Tapan M. Blood Adv Research Letter The American Society of Hematology 2022-04-12 /pmc/articles/PMC9996355/ /pubmed/35405739 http://dx.doi.org/10.1182/bloodadvances.2022007172 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Abbas, Hussein A. Sun, Hanxiao Pierce, Sherry Kanagal-Shamanna, Rashmi Li, Ziyi Yilmaz, Musa Borthakur, Gautam DiPippo, Adam J. Jabbour, Elias Konopleva, Marina Short, Nicholas J. DiNardo, Courtney Daver, Naval Ravandi, Farhad Kadia, Tapan M. Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy |
| title | Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy |
| title_full | Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy |
| title_fullStr | Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy |
| title_full_unstemmed | Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy |
| title_short | Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy |
| title_sort | validation of the alfa-1200 model in older patients with aml treated with intensive chemotherapy |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996355/ https://www.ncbi.nlm.nih.gov/pubmed/35405739 http://dx.doi.org/10.1182/bloodadvances.2022007172 |
| work_keys_str_mv | AT abbashusseina validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT sunhanxiao validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT piercesherry validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT kanagalshamannarashmi validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT liziyi validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT yilmazmusa validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT borthakurgautam validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT dipippoadamj validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT jabbourelias validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT konoplevamarina validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT shortnicholasj validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT dinardocourtney validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT davernaval validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT ravandifarhad validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy AT kadiatapanm validationofthealfa1200modelinolderpatientswithamltreatedwithintensivechemotherapy |